Effects of Wortmannin combined with mitomycin C on proliferation and apoptosis of HepG-2 cells
Zhang Jian,Wang Honglin,Zhang Qian,Zhao Yuan
DOI: https://doi.org/10.16016/j.1000-5404.2010.14.026
2010-01-01
Abstract:Objective To investigate the effects of Wortmannin combined with mitomycin C (MMC) on the proliferation,apoptosis and expressions of related genes Cyclin D1 and Bad in liver cancer cell line HepG-2. Methods HepG-2 cells (104/ml) were treated with 0,25,50,100,200 or 400 nmol/L Wortmannin,0,1.75,3.75,7.5,15 or 30 nmol/L MMC,or combined concentrations (0,26.875,53.75,107.5,215 or 430 nmol/L) respectively. Cell suppression rate were detected by MTT assay. Nucleus apoptosis of Hep-G-2 cells were examined by Hochest 33258 fluorescent staining. Change of cell cycle and apoptosis in HepG-2 cells were detected by flow cytometry (FCM). Expressions of PI3K/Akt signaling transduction pathway related genes and proteins were tested by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis. Results The inhibition ratio of cell proliferation was significant higher in combined groups than in either single groups (P<0.05). FCM showed HepG-2 cells were arrested at G0/G1 phrase,and apoptotic rate were increased from (3.23±1.32)% in control to (14.82±1.36)% in combined use of Wortmannin and MMC for 24 h (P<0.01). Typical changes in apoptotic morphology of HepG-2 cells were observed by fluorescence microscopy. Activation of p-Akt was inhibited,and mRNA and protein levels of Cyclin D1 were decreased,but those of Bad were increased. Conclusion Combined use of Wortmannin and MMC has a synergic antineoplastic effect on HepG-2 cells.